Boston, MA · Founded 2022 · Privately Held (backing)
Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. Stellaromics is based in Boston, MA and was founded in 2022. Its last reported valuation was $163 million in Dec 2024. It has raised $105 million.
Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$105.0M
Last round
—
Team — not yet on record
No current team members for Stellaromics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stellaromics with a free account
·Watch Stellaromics: the Monday email on marks, rounds and moves
